Skip to Main Navigation
Skip to Page Content
Share This:

Target Organs and Levels of Evidence for TR-043

Bioassay of Emetine for Possible Carcinogenicity (CASRN 483-18-1)

Chemical (Study Title)
Peer Review DatePrimary UsesRoute/Exposure LevelsStudy Laboratory
Emetine hydrochloride
11/28/1978Treatment of amoebic infection and in combination cancer therapy.Intraperitoneal Injection
R: 0,0.5,1.0, M: 0,1.6,3.2,6.4 MG/KG/35 PER GROUP
Southern Research Institute

Levels of Evidence

Male Rats: Inadequate Study
Female Rats: Inadequate Study
Male Mice: Inadequate Study
Female Mice: Inadequate Study